Zevra Therapeutics (ZVRA) Tax Provisions (2014 - 2026)
Zevra Therapeutics (ZVRA) reported Tax Provisions of $6.9 million for Q1 2026, up 484.94% on a YoY basis from $1.2 million in Q1 2025, and up 1280.04% quarter-over-quarter from $501000.0 in Q4 2025.
Zevra Therapeutics (ZVRA) Tax Provisions (2014 - 2026) Analysis & Trends
Zevra Therapeutics has reported Tax Provisions for 13 years, with the latest figure at $6.9 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 484.94% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $9.2 million (down 44.77% YoY), and the FY2025 full-year result was $3.4 million, down 77.56% from the prior year.
- Tax Provisions for Q1 2026 stood at $6.9 million, up from $501000.0 in the prior quarter.
- The five-year high for Tax Provisions was $15.4 million in Q4 2024, with the low at -$786000.0 in Q4 2022.
- Historically, Tax Provisions has averaged $1.8 million across 5 years, with a median of $54000.0 in 2022.
- Annual changes were most pronounced in 2022 — Tax Provisions tumbled 2411.76% — and 2025, when it soared 3041.43%.
- Zevra Therapeutics' Tax Provisions stood at -$786000.0 in 2022, then jumped by 122.52% to $177000.0 in 2023, then surged by 8584.18% to $15.4 million in 2024, then plunged by 96.74% to $501000.0 in 2025, then surged by 1280.04% to $6.9 million in 2026.
- The last three Tax Provisions figures came in at $6.9 million (Q1 2026), $501000.0 (Q4 2025), and -$433000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Zevra Therapeutics | 796.95 Mn | 596.33 Mn | 34.30 Mn | 6.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.91 Mn |
| Dec 31, 2025 | 501,000.00 |
| Sep 30, 2025 | -433,000.00 |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Sep 30, 2023 | 177,000.00 |
| Jun 30, 2023 | -74,000.00 |
| Mar 31, 2023 | -103,000.00 |
| Dec 31, 2022 | -786,000.00 |
| Sep 30, 2022 | -33,000.00 |
| Jun 30, 2022 | 38,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2020 | -34,000.00 |
| Dec 31, 2019 | -8,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | -9,000.00 |
| Mar 31, 2019 | -8,000.00 |